These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8344645)

  • 21. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
    Ghigo E; Bellone J; Aimaretti G; Bellone S; Loche S; Cappa M; Bartolotta E; Dammacco F; Camanni F
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.
    Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects.
    Ghigo E; Ceda GP; Valcavi R; Goffi S; Zini M; Mucci M; Valenti G; Cocchi D; Müller EE; Camanni F
    J Endocrinol Invest; 1994 Feb; 17(2):113-7. PubMed ID: 8006330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients.
    Grottoli S; Razzore P; Arvat E; Oleandri SE; Rossetto R; Ciccarelli E; Camanni F; Ghigo E
    J Endocrinol Invest; 1997 Nov; 20(10):597-602. PubMed ID: 9438917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
    Beccaria L; Marziani E; Manzoni P; Arvat E; Valetto MR; Gianotti L; Ghigo E; Chiumello G
    Dement Geriatr Cogn Disord; 1998; 9(2):78-81. PubMed ID: 9524798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GH secretion in Prader-Labhard-Willi syndrome: somatotrope responsiveness to GHRH is enhanced by arginine but not by pyridostigmine.
    Beccaria L; Bosio L; Sanzari A; Aimaretti G; Ghigo E; Chiumello G
    J Pediatr Endocrinol Metab; 1996; 9(6):577-83. PubMed ID: 9004172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy.
    Giustina A; Bossoni S; Bodini C; Girelli A; Balestrieri GP; Pizzocolo G; Wehrenberg WB
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1301-5. PubMed ID: 1592874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults.
    Ghigo E; Arvat E; Valente F; Nicolosi M; Boffano GM; Procopio M; Bellone J; Maccario M; Mazza E; Camanni F
    Neuroendocrinology; 1991 Sep; 54(3):291-4. PubMed ID: 1944815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children.
    Bellone J; Bartolotta E; Cardinale G; Arvat E; Cherubini V; Aimaretti G; Maccario M; Mucci M; Camanni F; Ghigo E
    J Endocrinol Invest; 1993; 16(7):521-5. PubMed ID: 8227981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood.
    Bellone J; Aimaretti G; Valetto MR; Bellone S; Baffoni C; Arvat E; Seminara S; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Oct; 135(4):421-4. PubMed ID: 8921823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
    Slowinska-Srzednicka J; Zgliczynski W; Makowska A; Jeske W; Brzezinska A; Soszynski P; Zgliczynski S
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.
    Broglio F; Benso A; Gottero C; Vito LD; Aimaretti G; Fubini A; Arvat E; Bobbio M; Ghigo E
    Eur J Endocrinol; 2000 Feb; 142(2):157-63. PubMed ID: 10664524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging.
    Arvat E; Ceda GP; Di Vito L; Ramunni J; Gianotti L; Broglio F; Deghenghi R; Ghigo E
    Pituitary; 1998 Apr; 1(1):51-8. PubMed ID: 11081183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of arginine on the GHRH-stimulated GH secretion in patients with hyperthyroidism.
    Giustina A; Schettino M; Bussi AR; Legati F; Licini M; Zuccato F; Wehrenberg WB
    Horm Res; 1992; 38(5-6):256-9. PubMed ID: 1307747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism.
    Del Rio G; Carani C; Velardo A; Zizzo G; Procopio M; Coletta F; Marrama P; Ghigo E
    J Endocrinol Invest; 1995 Oct; 18(9):690-5. PubMed ID: 8719299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man.
    Arvat E; Ghigo E; Nicolosi M; Boffano GM; Bellone J; Yin-Zhang W; Mazza E; Camanni F
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):347-50. PubMed ID: 1385023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children.
    Ghigo E; Procopio M; Bellone J; Mazza E; Mucci M; Boghen MF; Müller EE; Camanni F
    J Clin Endocrinol Metab; 1991 Feb; 72(2):467-70. PubMed ID: 1991816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging.
    Ghigo E; Goffi S; Arvat E; Imperiale E; Boffano GM; Valetto MR; Mazza E; Santi I; Magliona A; Boghen MF
    J Endocrinol Invest; 1992 Oct; 15(9):665-70. PubMed ID: 1479149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.
    De Marinis L; Folli G; D'Amico C; Mancini A; Sambo P; Tofani A; Oradei A; Barbarino A
    J Clin Endocrinol Metab; 1988 Mar; 66(3):598-604. PubMed ID: 3127419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency.
    Maccario M; Valetto MR; Savio P; Aimaretti G; Baffoni C; Procopio M; Grottoli S; Oleandri SE; Arvat E; Ghigo E
    Int J Obes Relat Metab Disord; 1997 Jan; 21(1):27-32. PubMed ID: 9023597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.